In RA patients, increased TIGIT expression correlated with disease activity, was an independent predictor of RA treatment response, and inhibited CD4 T cell effector responses such as cell proliferation and secretion of proinflammatory cytokines IFN-γ and IL-17 (19, 20). The gene discussed is CD4; the disease is rheumatoid arthritis.